MedPath

Ademetionine

Generic Name
Ademetionine
Drug Type
Small Molecule
Chemical Formula
C15H22N6O5S
CAS Number
29908-03-0
Unique Ingredient Identifier
7LP2MPO46S

Overview

Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)

Background

Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)

Indication

S-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as a dietary supplement for the support of bone and joint health, as well as mood and emotional well being.

Associated Conditions

  • Fatigue
  • Intrahepatic Cholestasis
  • Major Depressive Disorder (MDD)

Research Report

Published: May 13, 2025

Ademetionine Report

Name: Ademetionine Name (English): Ademetionine DrugBank ID: DB00118 Type: Small Molecule CAS Number: 29908-03-0

Uses: Ademetionine is used to treat various conditions, including:

  • Liver diseases (e.g., cholestatic liver diseases, alcoholic fatty liver disease, non-alcoholic fatty liver disease, liver disease during pregnancy, liver conditions with reduced bile formation).
  • Depression.
  • Osteoarthritis (to reduce pain and swelling in the joints).
  • Biliary cholangitis (an autoimmune disease of the liver).
  • Excess cholesterol in bile and biliary and liver diseases caused by cystic fibrosis.
  • Fibromyalgia symptoms.
  • Nerve problems in people with AIDS.
  • Sexual dysfunction in men with depression.

Mechanism of Action: Ademetionine (S-adenosylmethionine or SAMe) is a naturally occurring compound involved in several crucial biological processes:

  • Methylation: It acts as a methyl donor in the transfer of a methyl group to other molecules like DNA, proteins, and lipids, which is essential for gene expression, protein function, and lipid metabolism.
  • Trans-sulfuration: It participates in the synthesis of cysteine and glutathione, a vital antioxidant that protects liver cells from toxins and oxidative stress.
  • Aminopropylation: It is a precursor in the synthesis of polyamines, which are involved in cellular growth and repair. In liver disease, ademetionine helps maintain glutathione levels, minimizing liver damage and preventing the accumulation of lipids associated with cirrhosis. In depression, it affects neurotransmitters like serotonin, which regulate mood. In osteoarthritis, it may stimulate cartilage production and reduce inflammation.

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/10
Not Applicable
Recruiting
General Hospital of Shenyang Military Region
2023/11/18
Phase 3
Recruiting
2020/11/10
Phase 1
Completed
2020/02/05
Phase 4
Active, not recruiting
Oslo University Hospital
2020/01/31
Phase 2
Recruiting
2016/09/21
Phase 4
Terminated
University of Chile
2015/12/31
Not Applicable
Completed
2014/09/04
Not Applicable
Completed
2014/07/25
Phase 3
Completed
2013/12/02
Phase 4
UNKNOWN
Zhejiang Hisun Pharmaceutical Co. Ltd.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Ademetionine 1,4-Butanedisulfonate Enteric Coated Tablets
国药准字H20249303
化学药品
片剂
11/5/2024
Ademetionine 1,4-Butanedisulfonate Enteric Coated Tablets
abbott laboratories (m) sdn. bhd
国药准字HJ20150629
化学药品
片剂
7/24/2020
Ademetionine 1,4-Butanedisulfonate Enteric Coated Tablets
国药准字H20133197
化学药品
片剂
1/18/2023
Ademetionine 1,4 - Butanedisulfonate for injection
国药准字H20244834
化学药品
注射剂
9/10/2024
Ademetionine 1,4 - Butanedisulfonate for injection
国药准字H20213159
化学药品
注射剂
3/9/2021
Ademetionine 1,4 - Butanedisulfonate for injection
国药准字H20249623
化学药品
注射剂
12/1/2024
Ademetionine 1,4 - Butanedisulfonate for injection
国药准字H20249503
化学药品
注射剂
12/1/2024
Ademetionine 1,4 - Butanedisulfonate for injection
abbott laboratories de mexico,s.a. de c.v.
国药准字HJ20171084
化学药品
注射剂
9/18/2021
Ademetionine 1,4 - Butanedisulfonate for injection
国药准字H20103110
化学药品
注射剂
9/3/2024
Ademetionine 1,4 - Butanedisulfonate for injection
abbott laboratories de mexico,s.a. de c.v.
国药准字HJ20171069
化学药品
注射剂
9/18/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath